- Report
- May 2023
- 21 Pages
Italy
From €2770EUR$2,995USD£2,312GBP
- Report
- May 2023
- 21 Pages
France
From €2770EUR$2,995USD£2,312GBP
- Report
- May 2023
- 21 Pages
United Kingdom
From €2770EUR$2,995USD£2,312GBP
- Report
- May 2023
- 21 Pages
United States
From €2770EUR$2,995USD£2,312GBP
- Report
- November 2022
- 107 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- March 2026
- 90 Pages
Indonesia
From €2636EUR$2,850USD£2,200GBP
- Report
- February 2026
- 90 Pages
Japan
From €2636EUR$2,850USD£2,200GBP
- Report
- August 2025
- 145 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- February 2025
- 148 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- December 2024
- 120 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- April 2024
- 134 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- January 2024
- 140 Pages
Global
From €3931EUR$4,250USD£3,281GBP
- Report
- September 2023
- 143 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- May 2024
- 126 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- December 2023
- 140 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- March 2026
- 150 Pages
Canada
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 150 Pages
China
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 150 Pages
Germany
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 150 Pages
India
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 314 Pages
Canada
From €4486EUR$4,850USD£3,744GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more